138 related articles for article (PubMed ID: 35219948)
1. Design, synthesis, and tumor drug resistance reversal activity of novel hederagenin derivatives modified by nitrogen-containing heterocycles.
Huang W; Wang Y; Xu S; Qiao H; Cheng H; Wang L; Liu S; Tian Q; Wang R; Wang H; Bi Y
Eur J Med Chem; 2022 Mar; 232():114207. PubMed ID: 35219948
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.
Wang B; Liu S; Huang W; Ma M; Chen X; Zeng W; Liang K; Wang H; Bi Y; Li X
Eur J Med Chem; 2021 Feb; 211():113107. PubMed ID: 33360797
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of ocotillol derivatives fused with 2-aminothiazole via A-ring as modulators of P-glycoprotein-mediated multidrug resistance.
Wang Y; Zhang D; Ma G; Su Z; Liu M; Wang R; Meng Q; Bi Y; Wang H
Eur J Med Chem; 2022 Dec; 243():114784. PubMed ID: 36167009
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel H6 analogues as drug resistance reversal agents.
Wang X; Ren QW; Liu XX; Yang YT; Wang BH; Zhai R; Qi JG; Tian JW; Wang HB; Bi Y
Eur J Med Chem; 2019 Jan; 161():364-377. PubMed ID: 30384042
[TBL] [Abstract][Full Text] [Related]
5. H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo.
Yang Y; Guan D; Lei L; Lu J; Liu JQ; Yang G; Yan C; Zhai R; Tian J; Bi Y; Fu F; Wang H
Toxicol Appl Pharmacol; 2018 Feb; 341():98-105. PubMed ID: 29408042
[TBL] [Abstract][Full Text] [Related]
6. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
9. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
[TBL] [Abstract][Full Text] [Related]
12. Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance.
Wang C; Gao M; Liu S; Zou Z; Ren R; Zhang C; Xie H; Sun J; Qi Y; Qu Q; Song Z; Yang G; Wang H
Eur J Med Chem; 2021 Apr; 216():113317. PubMed ID: 33706147
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
Jin J; Wang FP; Wei H; Liu G
Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
[TBL] [Abstract][Full Text] [Related]
15. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
16. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
Chen LM; Liang YJ; Zhang X; Su XD; Dai CL; Wang FP; Yan YY; Tao LY; Fu LW
Anticancer Res; 2009 Nov; 29(11):4597-604. PubMed ID: 20032409
[TBL] [Abstract][Full Text] [Related]
17. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo.
Shi Z; Liang YJ; Chen ZS; Wang XW; Wang XH; Ding Y; Chen LM; Yang XP; Fu LW
Cancer Biol Ther; 2006 Jan; 5(1):39-47. PubMed ID: 16319528
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells.
Gao L; Zhao P; Li Y; Yang D; Hu P; Li L; Cheng Y; Yao H
Biochem Cell Biol; 2020 Aug; 98(4):484-491. PubMed ID: 31967866
[TBL] [Abstract][Full Text] [Related]
19. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
20. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]